Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line

Molecular and Cellular Biochemistry

Volumn 360, Issue 1-2, 2012, Pages 329-337

  Lu, Jin Jian ^a,b   Chen, Si Meng ^b   Ding, Jian ^b   Meng, Ling Hua ^b  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Anti tumor; Dihydroartemisinin; HCT116; Proteomics; Resistant

Indexed keywords

ANNEXIN; ARTEMISININ; ARTESUNATE; CAMPTOTHECIN; DIHYDROARTEMISININ; DOXORUBICIN; GLYCOPROTEIN P; HEAT SHOCK PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANNEXINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; CARCINOMA; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HCT116 CELLS; HEAT-SHOCK PROTEINS; HUMANS; PHOSPHOPYRUVATE HYDRATASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ARTESUNATE;

EID: 83555163925     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1072-2     Document Type: Article

References (36)

1. E Hsu 2006 The history of qing hao in the Chinese materia medica Trans R Soc Trop Med Hyg 100 505 508 16566952 10.1016/j.trstmh.2005.09.020 1:CAS:528:DC%2BD28XkvF2lsrw%3D
2. JJ Lu LH Meng YJ Cai Q Chen LJ Tong LP Lin J Ding 2008 Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species Cancer Biol Ther 7 1017 1023 18414062 10.4161/cbt.7.7.6035 1:CAS:528:DC%2BD1cXhtFWhs7vM
3. J Hou D Wang R Zhang H Wang 2008 Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action Clin Cancer Res 14 5519 5530 18765544 10.1158/1078-0432.CCR-08-0197 1:CAS:528:DC%2BD1cXhtVKmsbnE
4. W Nam J Tak JK Ryu M Jung JI Yook HJ Kim IH Cha 2007 Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells Head Neck 29 335 340 17163469 10.1002/hed.20524 (Pubitemid 46623498)
5. AE Mercer JL Maggs XM Sun GM Cohen J Chadwick PM O'Neill BK Park 2007 Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds J Biol Chem 282 9372 9382 17227762 10.1074/jbc.M610375200 1:CAS:528:DC%2BD2sXjtlCitrw%3D (Pubitemid 47104599)
6. Y Jiao CM Ge QH Meng JP Cao J Tong SJ Fan 2007 Dihydroartemisinin is an inhibitor of ovarian cancer cell growth Acta Pharmacol Sin 28 1045 1056 17588342 10.1111/j.1745-7254.2007.00612.x 1:CAS:528:DC%2BD2sXnvFynsLs%3D (Pubitemid 47020494)
7. GL Disbrow AC Baege KA Kierpiec H Yuan JA Centeno CA Thibodeaux D Hartmann R Schlegel 2005 Dihydroartemisinin is cytotoxic to papillomavirus- expressing epithelial cells in vitro and in vivo Cancer Res 65 10854 10861 16322232 10.1158/0008-5472.CAN-05-1216 1:CAS:528:DC%2BD2MXht1Kjsr%2FP (Pubitemid 41713353)
8. JJ Lu SM Chen XW Zhang J Ding LH Meng 2011 The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells Invest New Drugs 29 1276 1283 20607588 10.1007/s10637-010-9481-8 1:CAS:528:DC%2BC3MXhtFyjsb3I
9. T Chen M Li R Zhang H Wang 2009 Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy J Cell Mol Med 13 1358 1370 18466355 10.1111/j.1582-4934.2008.00360.x 1:CAS:528:DC%2BD1MXhtFCku7bE
10. LN Li HD Zhang SJ Yuan ZY Tian L Wang ZX Sun 2007 Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway Int J Cancer 121 1360 1365 17520675 10.1002/ijc.22804 1:CAS:528:DC%2BD2sXhtVSmtL%2FK (Pubitemid 47293806)
11. H Chen B Sun S Pan H Jiang X Sun 2009 Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo Anticancer Drugs 20 131 140 19209030 10.1097/CAD.0b013e3283212ade
12. P Reungpatthanaphong S Mankhetkorn 2002 Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines Biol Pharm Bull 25 1555 1561 12499639 10.1248/bpb.25.1555 1:CAS:528:DC%2BD3sXktFCq (Pubitemid 39663669)
13. T Efferth A Sauerbrey A Olbrich E Gebhart P Rauch HO Weber JG Hengstler ME Halatsch M Volm KD Tew DD Ross JO Funk 2003 Molecular modes of action of artesunate in tumor cell lines Mol Pharmacol 64 382 394 12869643 10.1124/mol.64.2.382 1:CAS:528:DC%2BD3sXlvVCns7k%3D (Pubitemid 36910002)
14. T Efferth M Davey A Olbrich G Rucker E Gebhart R Davey 2002 Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells Blood Cells Mol Dis 28 160 168 12064912 10.1006/bcmd.2002.0492 (Pubitemid 34743750)
15. M Michaelis MC Kleinschmidt S Barth F Rothweiler J Geiler R Breitling B Mayer H Deubzer O Witt J Kreuter HW Doerr J Cinatl J Cinatl Jr 2010 Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines Biochem Pharmacol 79 130 136 19698702 10.1016/j.bcp.2009.08.013 1:CAS:528:DC%2BD1MXhsVWqtbnL
16. S Zhang GS Gerhard 2009 Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target PLoS One 4 e7472 19862332 10.1371/journal.pone.0007472
17. LH Stockwin B Han SX Yu MG Hollingshead MA ElSohly W Gul D Slade AM Galal DL Newton MA Bumke 2009 Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction Int J Cancer 125 1266 1275 19533749 10.1002/ijc.24496 1:CAS:528:DC%2BD1MXovVelsbc%3D
18. JJ Lu LH Meng UT Shankavaram CH Zhu LJ Tong G Chen LP Lin JN Weinstein J Ding 2010 Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells Biochem Pharmacol 80 22 30 20206143 10.1016/j.bcp.2010.02.016 1:CAS:528:DC%2BC3cXlt1Cgtbc%3D
19. Z Tao Y Zhou J Lu W Duan Y Qin X He L Lin J Ding 2007 Caspase-8 preferentially senses the apoptosis-inducing action of NG-18, a gambogic acid derivative, in human leukemia HL-60 cells Cancer Biol Ther 6 691 696 17426447 10.4161/cbt.6.5.3960 1:CAS:528:DC%2BD2sXhtVyrsrvJ (Pubitemid 47328349)
20. XS Jiang LY Tang XJ Cao H Zhou QC Xia JR Wu R Zeng 2005 Two-dimensional gel electrophoresis maps of the proteome and phosphoproteome of primitively cultured rat mesangial cells Electrophoresis 26 4540 4562 16315178 10.1002/elps.200500286 1:CAS:528:DC%2BD2MXhtleks7bK (Pubitemid 41819577)
21. C Riganti S Doublier D Viarisio E Miraglia G Pescarmona D Ghigo A Bosia 2009 Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression Br J Pharmacol 156 1054 1066 19298255 10.1111/j.1476-5381.2009.00117.x 1:CAS:528:DC%2BD1MXltFSmurg%3D
22. F Gong X Peng Z Zeng M Yu Y Zhao A Tong 2011 Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method Mol Cell Biochem 348 141 147 21080034 10.1007/s11010-010-0648-6 1:CAS:528:DC%2BC3MXis1aktQ%3D%3D
23. QL Sun HF Sha XH Yang GL Bao J Lu YY Xie 2011 Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-taxol J Cancer Res Clin Oncol 137 521 532 20499251 10.1007/s00432-010-0913-9 1:CAS:528:DC%2BC3MXhvV2htr8%3D
24. YX Yang ZQ Xiao ZC Chen GY Zhang H Yi PF Zhang JL Li G Zhu 2006 Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR Proteomics 6 2009 2021 16525997 10.1002/pmic.200402031 1:CAS:528:DC%2BD28XjtlKmtL8%3D
25. S Mori-Iwamoto Y Kuramitsu S Ryozawa K Mikuria M Fujimoto S Maehara Y Maehara K Okita K Nakamura I Sakaida 2007 Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine Int J Oncol 31 1345 1350 17982661 1:CAS:528:DC%2BD2sXhsVKgtbbP
26. YH Jin K Kita Z Sun XB Tong H Nie N Suzuki 2009 The roles of HSP27 and annexin II in resistance to UVC-induced cell death: comparative studies of the human UVC-sensitive and -resistant cell lines RSa and APr-1 Biosci Biotechnol Biochem 73 1318 1322 19502736 10.1271/bbb.80841 1:CAS:528:DC%2BD1MXos1Ghsrw%3D
27. S Chuthapisith R Layfield ID Kerr C Hughes O Eremin 2007 Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs Int J Oncol 30 1545 1551 17487377 1:CAS:528: DC%2BD2sXntVCnsbg%3D
28. X Yan J Yin H Yao N Mao Y Yang L Pan 2010 Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer Cancer Res 70 1616 1624 20103635 10.1158/0008-5472.CAN-09-3215 1:CAS:528:DC%2BC3cXhvFaktr4%3D
29. XD Yan LY Pan Y Yuan JH Lang N Mao 2007 Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines J Proteome Res 6 772 780 17269733 10.1021/pr060402r 1:CAS:528:DC%2BD28Xhtlaru7jO (Pubitemid 46340180)
30. A Subramanian DM Miller 2000 Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene J Biol Chem 275 5958 5965 10681589 10.1074/jbc.275.8.5958 1:CAS:528:DC%2BD3cXhsFKku7g%3D (Pubitemid 30115245)
31. E Hernlund E Hjerpe E Avall-Lundqvist M Shoshan 2009 Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-d-glucose treatment Mol Cancer Ther 8 1916 1923 19567816 10.1158/1535-7163.MCT-09-0179 1:CAS:528:DC%2BD1MXosVymsLk%3D
32. J Adams 2004 The proteasome: a suitable antineoplastic target Nat Rev Cancer 4 349 360 15122206 10.1038/nrc1361 1:CAS:528:DC%2BD2cXjsFSlu7k%3D (Pubitemid 38579481)
33. G Nalepa M Rolfe JW Harper 2006 Drug discovery in the ubiquitin-proteasome system Nat Rev Drug Discov 5 596 613 16816840 10.1038/nrd2056 1:CAS:528:DC%2BD28XmsVagsro%3D (Pubitemid 43971194)
34. S Lu Z Chen J Yang L Chen S Gong H Zhou L Guo J Wang 2008 Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line Exp Hematol 36 1278 1284 18562081 10.1016/j.exphem.2008.04.013 1:CAS:528:DC%2BD1cXhtFylsLvE
35. R Oerlemans NE Franke YG Assaraf J Cloos I van Zantwijk CR Berkers GL Scheffer K Debipersad K Vojtekova C Lemos JW van der Heijden B Ylstra GJ Peters GL Kaspers BA Dijkmans RJ Scheper G Jansen 2008 Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein Blood 112 2489 2499 18565852 10.1182/blood-2007-08-104950 1:CAS:528:DC%2BD1cXhtFCru7zO
36. B Bachmeier I Fichtner PH Killian E Kronski U Pfeffer T Efferth 2011 Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells PLoS One 6 e20550 21637790 10.1371/journal.pone.0020550 1:CAS:528:DC%2BC3MXntVait7k%3D